🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

Within moments of entering one group, a vendor shared contact information, where most transactions occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Details and Costs

Within these communities, messages show dark colored parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially significant health risks”.